Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2014Molecular Cancer Research

Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane–Induced Death by AS101 via Inhibition of the VLA-4–IL10–Survivin Axis

View Full Paper
Ask AI
Bookmark
Share

Authors

HDHila DanochYKYona KalechmanMAMichael Albeck

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Danoch et al. (2014) studied this question.

synapsesocial.com/papers/6a7041aff44fa9f079ddd4dchttps://doi.org/10.1158/1541-7786.mcr-14-0459
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer2009 · 686 citations
  2. 2Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL2013 · 193 citations
  3. 3Ammonium Trichloro(dioxoethylene-<b><i>o,o</i></b>′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop2004 · 96 citations
  4. 4Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention2002 · 136 citations
  5. 5Differential requirements for survivin in hematopoietic cell development2005 · 90 citations